Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Research and Development Expenses (Tables)

v3.19.1
Research and Development Expenses (Tables)
12 Months Ended
Dec. 31, 2018
Research And Development Expenses  
Schedule of research and development expenses
   

Year ended

December 31,

 
    2018     2017     2016  
    USD  
                   
Clinical and preclinical trials   $ 4,768     $ 3,809     $ 5,104  
Salary and related expenses     909       888       664  
Patents     229       234       198  
Royalties     14       11       11  
Laboratory materials     73       63       38  
Rent     51       51       48  
Depreciation     3       3       4  
Others     28       47       48  
                         
    $ 6,075     $ 5,106     $ 6,115